Cardiol Therapeutics (CRDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -17,941 | -12,094 | -7,070 | -25,244 | -20,163 |
| Depreciation Amortization | 124 | 84 | 42 | 176 | 131 |
| Accounts receivable | -68 | -47 | -18 | -48 | -52 |
| Other Working Capital | 2,919 | 2,245 | 58 | 61 | -1,041 |
| Other Operating Activity | 945 | -683 | -140 | 6,264 | 5,600 |
| Operating Cash Flow | $-14,021 | $-10,495 | $-7,128 | $-18,791 | $-15,525 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -21 | -14 | -12 | -10 | -10 |
| Investing Cash Flow | $-21 | $-14 | $-12 | $-10 | $-10 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | 78,777 | 28,281 |
| Other Financing Activity | -31 | -21 | -10 | -4,223 | -1,126 |
| Financing Cash Flow | $-31 | $-21 | $-10 | $74,554 | $27,155 |
| Beginning Cash Position | 64,284 | 65,701 | 66,247 | 11,191 | 11,142 |
| End Cash Position | 50,211 | 55,172 | 59,097 | 66,943 | 22,762 |
| Net Cash Flow | $-14,073 | $-10,529 | $-7,150 | $55,752 | $11,620 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,021 | -10,495 | -7,128 | -18,791 | -15,525 |
| Capital Expenditure | -21 | -14 | -12 | -10 | -10 |
| Free Cash Flow | -14,042 | -10,508 | -7,140 | -18,802 | -15,536 |